688136.SHG Shandong Kexing Bioproducts Co. Ltd. A

Healthcare Pharmaceuticals Shanghai Stock Exchange
15.53 CNY
Close of Nov 4, 2026
14.57 37.83
Market cap
CNY 3.14B
P/E
42.0x
P/B
1.66x
ROE
14.6%
Dividend yield
1.83%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 688136.SHG undervalued?

Graham number
Price15.53
Graham value8.82
Premium76.1%

688136.SHG trades 76.1% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Shandong Kexing Bioproducts Co. Ltd. A fundamental analysis

No fundamental analysis for Shandong Kexing Bioproducts Co. Ltd. A yet.

Shandong Kexing Bioproducts Co. Ltd. A stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Shandong Kexing Bioproducts Co. Ltd. A

Kexing Biopharm Co., Ltd., a biopharmaceutical company, engages in the research and development, production, and sale of recombinant protein drugs and microecological preparations in China, the European Union, Brazil, the Philippines, and Indonesia. The company focuses on oncology, immunology, and degenerative diseases; and develops new antibodies, proteins, nucleic acid drugs, and antiviral therapy, as well as for the treatment of tumor, autoimmune, metabolic diseases, and …

Full company profile